Additionally, combination therapies targeting apoptosis with other pathways are being tested for Parkinson’s and Alzheimer’s disease including antioxidants, cell cycle inhibitors, JNK inhibitors, GSK3β inhibitors, and STATINS [54], which could also be suitable strategy for delaying the progression of in SMA. This evidence concerns the gene GSK3B and Parkinson disease.